SAN DIEGO, July 31, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the market launch of its proprietary new generation monitoring ...
SAN DIEGO, CA / ACCESS Newswire / May 3, 2026 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, today announced new translational research presented at Digestive Disease ...
Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to Subcutaneous Infliximab JERSEY CITY, NJ AND SAN DIEGO, CA / ACCESS Newswire / July ...
Translational Data Inform a Scalable, Noninvasive Test Designed to Identify Treatment-Eligible Patients and Enable Longitudinal Assessment as MASH Therapies Expand SAN DIEGO, CA / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results